Norepinephrine and vasopressin counteract anti-inflammatory effects of isoflurane in endotoxemic rats

International Journal of Molecular Medicine

Volumn 20, Issue 4, 2007, Pages 597-604

  Hofstetter, Christian ^a   Boost, Kim A ^a   Hoeg, Sandra ^a   Flondor, Michael ^a   Scheller, Bertram ^a   Muhl, Heiko ^a   Pfeilschifter, Josef ^a   Zwissler, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Endotoxemia; Inflammation; Isoflurane; Norepinephrine; Vasopressin

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; ISOFLURANE; LIPOPOLYSACCHARIDE; NITRITE; NORADRENALIN; OXYGEN; VASOPRESSIN DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; CELL CULTURE; CELL FRACTIONATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG INTERACTION; ENDOTOXEMIA; HEART RATE; HUMAN; LUNG ALVEOLUS MACROPHAGE; MALE; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; CELLS, CULTURED; CYTOKINES; DRUG INTERACTIONS; ENDOTOXEMIA; HEART RATE; HUMANS; ISOFLURANE; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; NITRITES; NOREPINEPHRINE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS; VASOPRESSINS;

EID: 38449100368     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.4.597     Document Type: Article

References (31)

1. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1478, 1993.
2. Reinhart K, Sakka SG and Meier-Hellmann A: Haemodynamic management of a patient with septic shock. Eur J Anaesthesiol 17: 6-7, 2000. (Pubitemid 30186634)
3. Takakura K, Taniguchi T, Muramatsu I, Takeuchi K and Fukuda S: Modification of alpha 1-adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Crit Care Med 30: 894-899, 2002. (Pubitemid 34297814)
4. Dunser MW, Mayr AJ, Ulmer H, Ritsch H, Knotzer H, Pajk W, Luckner G, Mutz NJ and Hasibeder WR: The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock. A retrospective analysis. Anesth Analg 93: 7-13, 2001.
5. Patel BM, Chittock DR, Russel JA and Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96: 576-582, 2002.
6. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Klogeras KT, Wilder R, Gold PW, Deuster PA and Chrousos GP: Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 271: E601-E605, 1996.
7. Meiser A and Laubenthal H: Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anesthesiol 19: 523-538, 2005.
8. Sackey PV, Martlinq CR, Granath F and Radell PJ: Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med 32: 2241-2246, 2004. (Pubitemid 39491803)
9. Mitsuhata H, Shimizu R and Yokoyama MM: Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol 17: 529-534, 1995.
10. Giraud O, Seince PF, Rolland C, Lecon-Malas V, Desmonts JM, Aubier M and Dehoux M: Halothane reduces the early lipopolysaccharide-induced lung inflammation in mechanically ventilated rats. Am J Respir Crit Care Med 162: 2278-2286, 2000.
11. Plachinta RV, Hayes JK, Cerilli LA and Rich GF: Isoflurane pretreatment inhibits lipopolysaccharide-induced inflammation in rats. Anesthesiology 98: 89-95, 2003.
12. Boost K, Hofstetter C, Flondor M, Betz C, Homann M, Pfeilschifter J, Muhl H and Zwissler B: Desflurane differentially affects the release of proinflammatory cytokines in plasma and bronchoalveolar fluid of endotoxemic rats. Int J Mol Med 17: 1139-1144, 2006.
13. Hofstetter C, Flondor M, Boost KA, Koehler P, Bosmann M, Pfeilschifter J, Zwissler B and Muhl H: A brief exposure to isoflurane (50s) significantly impacts on plasma cytokine levels in endotoxemic rats. Int Immunopharmacol 5: 1519-1522, 2005.
14. Bolke E, Jehle PM, Storck M, Braun C, Schams S, Steinbach S, Orth K, Gorich J, Scharrer-Pamler R and Sunder-Plassmann L: Endovascular stent-graft placement versus conventional open surgery in infrarenal aortic aneurysm: a prospective study on the acute phase response and clinical outcome. Clin Chim Acta 314: 203-207, 2001.
15. Bachetti T, Pasini E, Suzuki H and Ferrari R: Species-specifc modulation of the nitric oxide pathway after acute experimentally induced endotoxemia. Crit Care Med 31: 1509-1514, 2003.
16. Hofstetter C, Flondor M, Hoegl S, Muhl H and Zwissler B: Interleukin-10 aerosol reduces proinflammatory mediators in bronchoalveolar fluid of endotoxemic rats. Crit Care Med 33: 2317-2322, 2005.
17. Liu R, Ishbe Y and Ueda M: Isoflurane-sevoflurane administration before ischemia attenuates ischemia-reperfusion induced injury in isolated rat lungs. Anesthesiology 92: 833-840, 2000.
18. Lee HT, Ota-Setlik A, Fu Y, Nasr SH and Emala CW: Differential protective effects of volatile anesthetics against ischemia-reperfusion injury in vivo. Anesthesiology 101: 1313-1324, 2004.
19. Kim PK and Deutschman CS: Inflammatory response and mediators. Surg Clin North Am 80: 885-894, 2000.
20. 2+ homeostasis of cardiac myocytes. Circ Res 69: 540-550, 1991.
21. Shahani R, Klein LV, Marshall JG, Nicholson S, Rubin BB, Walker PM and Lindsay TF: Hemorrhage-induced alpha-adrenergic signaling results in myocardial TNF-alpha expression and contractile dysfunction. Am J Physiol Heart Circ Physiol 281: H84-H92, 2001.
22. Kan H, Xie Z and Finkel MS: Norepinephrine-stimulated MAP kinase activity enhances cytokine-induced NO production by rat cardiac myocytes. Am J Physiol 276: H47-H52, 1999.
23. Abraham E, Kaneko DJ and Shenkar R: Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am J Physiol 276: L1-L8, 1999.
24. Stover JF, Sakowitz OW, Schoning B, Rupprecht S, Kroppenstedt SN, Thomale UW, Woiciechowsky C and Unterberg AW: Norepinephrine infusion increases interleukin-6 in plasma and cerebrospinal fluid of brain-injured rats. Med Sci Monit 9: BR382-BR388, 2003.
25. Arcaroli J, Yang KY, Yum HK, Kupfner J, Pitts TM, Park JS, Strassheim D and Abraham E: Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. J Leukoc Biol 72: 571-579, 2002.
26. Bucher M, Hobbhahn J, Taeger K and Kurtz A: Cytokine-mediated downregulation of vasopressin V1A receptors during acute endotoxemia in rats. Am J Physiol Regul Integ Comp Physiol 282: R979-R984, 2002.
27. Chikanza IC and Grossman AS: Hypothalamic-pituitary-mediated immunomodulation. Arginine vasopressin is a neuroendocrine immune modulator. Br J Rheumatol 37: 131-136, 1998.
28. Zhao L and Brinton RD: Supression of proinflammatory cytokines interleukin-1ß and tumor necrosis factor-alpha in astrocytes by V1 vasopressin receptor agonist: A cAMP response element binding protein-dependent mechanism. J Neurosci 24: 2226-2235, 2004.
29. Moreau R, Barriere E, Tazi KA, Lardeux B, Dargere D, Urbanowicz W, Poirel O, Chauvelot-Moachon L, Guimont MC, Bernuau D and Lebrec D: Terlipressin inhibits in vivo aortic iNOS expression induced beta-lipopolysaccaride in rats with biliary cirrhosis. Hepatology 36: 1070-1078, 2002.
30. Dunser MW, Werner ER, Wenzel V, Ulmer H, Friesenecker BE, Hasibeder WR and Mayr AJ: Arginine vasopressin and serum nitrite/nitrate concentrations in advanced vasodilatory shock. Acta Anaesthesiol Scand 48: 814-819, 2004. (Pubitemid 38993095)
31. Tschaikowsky K, Ritter J, Schroeppel K and Kuehn M: Volatile anesthetics differentially affect immunostimulated expression of inducible nitric oxide synthase: Role of intracellular calcium. Anesthesiology 92: 1093-1102, 2000.